Data availability
Data and material are available on demand.
Code availability
Not applicable.
References
Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med. 2009;50:1076–87. https://doi.org/10.2967/jnumed.108.054478.
Valenta I, Dilsizian V, Quercioli A, Ruddy TD, Schindler TH. Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes. Curr Cardiol Rep. 2013;15:344. https://doi.org/10.1007/s11886-012-0344-0.
Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150–6. https://doi.org/10.1016/j.jacc.2009.02.069.
Nkoulou R, Fuchs TA, Pazhenkottil AP, Kuest SM, Ghadri JR, Stehli J, et al. Absolute myocardial blood flow and flow reserve assessed by gated SPECT with cadmium-zinc-telluride detectors using 99mTc-tetrofosmin: Head-to-head comparison with 13N-ammonia PET. J Nucl Med. 2016;57:1887–92. https://doi.org/10.2967/jnumed.115.165498.
Agostini D, Roule V, Nganoa C, Roth N, Baavour R, Parienti JJ, et al. First validation of myocardial flow reserve assessed by dynamic (99m)Tc-sestamibi CZT-SPECT camera: head to head comparison with (15)O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging. 2018;45:1079–90. https://doi.org/10.1007/s00259-018-3958-7.
Acampa W, Zampella E, Assante R, Genova A, De Simini G, Mannarino T, et al. Quantification of myocardial perfusion reserve by CZT-SPECT: a head to head comparison with (82)Rubidium PET imaging. J Nucl Cardiol. 2021;28:2827–39. https://doi.org/10.1007/s12350-020-02129-w.
Giubbini R, Bertoli M, Durmo R, Bonacina M, Peli A, Faggiano I, et al. Comparison between N(13)NH3-PET and (99m)Tc-tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve. J Nucl Cardiol. 2021;28:1906–18. https://doi.org/10.1007/s12350-019-01939-x.
Zavadovsky KV, Mochula AV, Maltseva AN, Shipulin VV, Sazonova SI, Gulya MO, et al. The current status of CZT SPECT myocardial blood flow and reserve assessment: tips and tricks. J Nucl Cardiol. 2021. https://doi.org/10.1007/s12350-021-02620-y.
Bailly M, Ribeiro MJ, Angoulvant D. Combining flow and reserve measurement during myocardial perfusion imaging: a new era for myocardial perfusion scintigraphy? Arch Cardiovasc Dis. 2021;114:818–27. https://doi.org/10.1016/j.acvd.2021.10.006.
Yamane T, Kondo A, Takahashi M, Miyazaki Y, Ehara T, Koga K, et al. Ultrafast bone scintigraphy scan for detecting bone metastasis using a CZT whole-body gamma camera. Eur J Nucl Med Mol Imaging. 2019;46:1672–7. https://doi.org/10.1007/s00259-019-04329-0.
Goshen E, Beilin L, Stern E, Kenig T, Goldkorn R, Ben-Haim S. Feasibility study of a novel general purpose CZT-based digital SPECT camera: initial clinical results. EJNMMI Phys. 2018;5:6. https://doi.org/10.1186/s40658-018-0205-z.
Melki S, Chawki MB, Marie PY, Imbert L, Verger A. Augmented planar bone scintigraphy obtained from a whole-body SPECT recording of less than 20 min with a high-sensitivity 360 degrees CZT camera. Eur J Nucl Med Mol Imaging. 2020;47:1329–31. https://doi.org/10.1007/s00259-019-04525-y.
Komber H, Little D, Cade S, Graham R, Redman S. Comparing the patient experience between a novel 360 degrees gamma camera (VERITON-CT) and a conventional dual head gamma camera. J Nucl Med Technol. 2021. https://doi.org/10.2967/jnmt.121.262627.
Mairal E, Imbert L, Marie PY, Bahloul A. Three-phase bone quantitative-SPECT of navicular bones with a high-sensitivity whole-body CZT-camera in a Mueller-Weiss syndrome. Eur J Nucl Med Mol Imaging. 2022;49:3295–6. https://doi.org/10.1007/s00259-022-05733-9.
Acknowledgements
We express our deepest gratitude to technical and radiopharmaceutical staff from CHR of Orleans and to the engineering team of GE Healthcare. This study is part of the French network of University Hospitals HUGO (“Hôpitaux Universitaires du Grand Ouest”).
Funding
This study was supported by CHR Orleans. The StarGuide system was provided by GE Healthcare during 1 year for evaluation.
Author information
Authors and Affiliations
Contributions
All authors have contributed to work and have read and approved the manuscript. Matthieu Bailly and Aurelien Callaud analyzed and interpreted the data. Matthieu Bailly drafted the manuscript. All authors revised it critically for important intellectual content.
Corresponding author
Ethics declarations
Ethics approval
The study protocol was approved by the Local and Regional Ethics Committees, and the procedures were in accordance with the Declaration of Helsinki.
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Not applicable.
Consent to participate
Patient received information and gave informed written consent.
Consent for publication
All authors consent to the publication of the manuscript.
Competing interests
Matthieu Bailly and Gilles Metrard received honoraria and travel grants from General Electric Healthcare (from previous and other works).
Trial Registration: LISSE1 (clinicaltrials.gov unique identifier NCT04704349). https://clinicaltrials.gov/ct2/show/study/NCT04704349
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image of the month
Rights and permissions
About this article
Cite this article
Bailly, M., Callaud, A. & Metrard, G. Dynamic cardiac SPECT with flow measurement using 3D-ring CZT: when SPECT is inspired by PET. Eur J Nucl Med Mol Imaging 50, 1837–1839 (2023). https://doi.org/10.1007/s00259-022-06106-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-022-06106-y